Bremer Trust National Association’s Quest Diagnostics DGX Stock Holding History

Bremer Trust National Association’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$20K	Buy	+240	New	+$22.5K	﹤0.01%	566

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bremer Trust National Association's DGX Position: Q4 2018 in Review

Bremer Trust National Association opened a new position in Quest Diagnostics (DGX) in Q4 2018: 240 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #566 among its holdings.

625 funds tracked by Wall St. Rank hold DGX as of Q4 2018.

Bremer Trust National Association held 240 shares of Quest Diagnostics worth $20K as of Q4 2018.
Quest Diagnostics was a new Bremer Trust National Association position in Q4 2018.
Quest Diagnostics made up ﹤0.01% of Bremer Trust National Association's portfolio in Q4 2018, its #566 holding.
625 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.